Michael Greiner - Mar 4, 2022 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP - Chief Financial Officer
Signature
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Stock symbol
AVNS
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
4
Date filed
3/8/2022, 10:28 AM
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $0 +30.6K +45.02% $0.00 98.5K Mar 4, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 4, 2023, 1/3 on March 4, 2024 and 1/3 on March 4, 2025.
F2 Total beneficially owned includes 184 shares acquired on December 31, 2020, 236 shares acquired on June 30, 2021 and 252 shares acquired on December 31, 2021 under the Issuer's Employee Stock Purchase Plan.